Taken together, our analyses suggest that inhibiting PLK1 promotes the apoptosis of HSCs by mitochondrial‐ and caspase‐dependent pathways in vivo and in vitro, providing evidence that inhibiting PLK1 ameliorates liver fibrosis. Here, PLK1 is linked to Hepatic fibrosis.